Back to mobile site
Get it on Google Play

Moderna and Oxford receive UK authorization for Lynch syndrome cancer vaccine trial

June 8, 2026 7:01 PM EDT Send to a Friend
Moderna Inc. (NASDAQ: MRNA) and the University of Oxford received authorization from the UK's Medicines and Healthcare products Regulatory Agency ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login